National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

oral fludarabine phosphate
An oral formulation of the phosphate salt of fludarabine, a synthetic purine nucleoside analogue antimetabolite with antineoplastic activity. Fudarabine is preferentially transported into malignant cells and metabolized by deoxycytidine kinase to its active form, 2-fluoro-ara-ATP; 2-fluoro-ara-ATP competes directly with deoxyadenosine triphosphate (dATP) and inhibits alpha DNA polymerase, RNA reductase, and DNA primase, which may result in inhibition of DNA synthesis and cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Foreign brand name:Fludara Oral
Code name:SH T 586



Previous:opioid growth factor, opium tincture, Optison, Ora-Testryl, Oracit
Next:oral Hsp90 inhibitor IPI-493, oral JAK inhibitor INCB18424, oral JAK2 inhibitor SB1518, oral microencapsulated diindolylmethane, oral milataxel

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov